ATE536885T1 - Produktion einer homogenen impfstoffzubereitung zur behandlung von krebs - Google Patents

Produktion einer homogenen impfstoffzubereitung zur behandlung von krebs

Info

Publication number
ATE536885T1
ATE536885T1 AT08757902T AT08757902T ATE536885T1 AT E536885 T1 ATE536885 T1 AT E536885T1 AT 08757902 T AT08757902 T AT 08757902T AT 08757902 T AT08757902 T AT 08757902T AT E536885 T1 ATE536885 T1 AT E536885T1
Authority
AT
Austria
Prior art keywords
cancer
treatment
production
vaccine preparation
homogeneous
Prior art date
Application number
AT08757902T
Other languages
English (en)
Inventor
Martoenez Gryssell Maria Rodroeguez
Rodroeguez Lisel Vina
Gonzalez Loany Calvo
Fiallo Ariadna Cuevas
Veliz Ernesto Chico
Ramos Tania Crombet
Novo Airama Albisa
Marinello Gisela Maria Gonzalez
Davila Agustin Bienvenido Lage
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40225717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE536885(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Application granted granted Critical
Publication of ATE536885T1 publication Critical patent/ATE536885T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00113—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT08757902T 2007-06-29 2008-06-26 Produktion einer homogenen impfstoffzubereitung zur behandlung von krebs ATE536885T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20070154A CU23652A1 (es) 2007-06-29 2007-06-29 Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención
PCT/CU2008/000005 WO2009003425A1 (es) 2007-06-29 2008-06-26 Obtención de un preparado vacunal homogéneo para el tratamiento del cáncer

Publications (1)

Publication Number Publication Date
ATE536885T1 true ATE536885T1 (de) 2011-12-15

Family

ID=40225717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08757902T ATE536885T1 (de) 2007-06-29 2008-06-26 Produktion einer homogenen impfstoffzubereitung zur behandlung von krebs

Country Status (31)

Country Link
US (2) US8778879B2 (de)
EP (1) EP2184072B1 (de)
JP (1) JP5368437B2 (de)
KR (1) KR20100039372A (de)
CN (1) CN101790383B (de)
AR (1) AR067085A1 (de)
AT (1) ATE536885T1 (de)
AU (1) AU2008271798B2 (de)
BR (1) BRPI0813662B8 (de)
CA (1) CA2692340C (de)
CL (1) CL2008001936A1 (de)
CO (1) CO6251274A2 (de)
CU (1) CU23652A1 (de)
CY (1) CY1112476T1 (de)
DK (1) DK2184072T3 (de)
EA (1) EA021905B1 (de)
ES (1) ES2379130T3 (de)
HK (1) HK1145979A1 (de)
HR (1) HRP20120218T1 (de)
JO (1) JO2777B1 (de)
MY (1) MY149136A (de)
NZ (1) NZ582829A (de)
PE (2) PE20131037A1 (de)
PL (1) PL2184072T3 (de)
PT (1) PT2184072E (de)
RS (1) RS52196B (de)
SI (1) SI2184072T1 (de)
TW (1) TWI409080B (de)
UY (1) UY31184A1 (de)
WO (1) WO2009003425A1 (de)
ZA (1) ZA201000609B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20200032A7 (es) * 2020-06-09 2022-01-13 Ct Inmunologia Molecular Composiciones vacunales basadas en nano-partículas de fosfatos de calcio para el tratamiento del cáncer
CN114594257B (zh) * 2022-05-09 2022-08-05 北京生物制品研究所有限责任公司 含CpG ODN的吸附型疫苗的解吸附组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237750T3 (es) 1993-12-09 2005-08-01 Centro De Inmunologia Molecular Vacuna que comprende factor de crecimiento epidermico autologo humano y su uso.
CA2261433A1 (en) * 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
CU23077A1 (es) * 2000-12-06 2005-08-17 Centro Inmunologia Molecular Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
CU22979A1 (es) * 2000-12-08 2004-09-09 Centro Inmunologia Molecular Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina
CU22999A1 (es) * 2001-12-04 2004-10-12 Centro Inmunologia Molecular Método de tratamiento de enfermedades malignas e infecciosas crónicas
GB0109297D0 (en) * 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
GB0405787D0 (en) * 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines

Also Published As

Publication number Publication date
TWI409080B (zh) 2013-09-21
US20100196412A1 (en) 2010-08-05
MY149136A (en) 2013-07-15
WO2009003425A1 (es) 2009-01-08
EP2184072A1 (de) 2010-05-12
PE20131037A1 (es) 2013-10-07
RS52196B (en) 2012-10-31
BRPI0813662B1 (pt) 2019-05-14
EA021905B1 (ru) 2015-09-30
NZ582829A (en) 2012-03-30
US8778879B2 (en) 2014-07-15
TW200918092A (en) 2009-05-01
ZA201000609B (en) 2010-10-27
EA201070080A1 (ru) 2010-12-30
KR20100039372A (ko) 2010-04-15
BRPI0813662A2 (pt) 2014-12-30
PE20090426A1 (es) 2009-05-05
US8841251B2 (en) 2014-09-23
JO2777B1 (en) 2014-03-15
UY31184A1 (es) 2009-01-05
BRPI0813662B8 (pt) 2021-05-25
SI2184072T1 (sl) 2012-04-30
PT2184072E (pt) 2012-03-21
EP2184072B1 (de) 2011-12-14
PL2184072T3 (pl) 2012-05-31
AU2008271798B2 (en) 2012-06-07
CN101790383B (zh) 2013-05-29
US20130039940A1 (en) 2013-02-14
HRP20120218T1 (hr) 2012-04-30
CO6251274A2 (es) 2011-02-21
EP2184072A4 (de) 2010-09-15
CA2692340C (en) 2015-11-17
CA2692340A1 (en) 2009-01-08
JP5368437B2 (ja) 2013-12-18
CL2008001936A1 (es) 2009-09-25
AR067085A1 (es) 2009-09-30
DK2184072T3 (da) 2012-04-02
HK1145979A1 (en) 2011-05-13
CU23652A1 (es) 2011-05-27
CN101790383A (zh) 2010-07-28
AU2008271798A1 (en) 2009-01-08
CY1112476T1 (el) 2015-12-09
ES2379130T3 (es) 2012-04-23
JP2010531817A (ja) 2010-09-30

Similar Documents

Publication Publication Date Title
DK2285779T3 (da) Fremgangsmåde til fremstilling af arylcarboxamider
DK3124610T3 (da) Hbv-behandling
FI20105642A (fi) Uusi menetelmä mikroselluloosan valmistamiseksi
DE502007003700D1 (de) Verfahren zur Herstellung von Glycerin
BR112012000434A2 (pt) procedimento para a fabricação de piscinas naturais.
DE102009012161B8 (de) Verfahren zur Herstellung von Polysaccharidderivaten
DK2350290T3 (da) Fremgangsmåde til fremstilling af sterile hanplanter
ES2627652T8 (es) Procedimiento para la fabricación de un conjunto de piedras de bisutería
DE502008000793D1 (de) Mehrstufiges Verfahren zur Herstellung von Aminoalkylgruppen aufweisenden Organopolysiloxanen
DK2151429T3 (da) Fremgangsmåde til fremstilling af agomelatin
DK3388111T3 (da) Organoarsenforbindelse til behandlingen af kræft
NO20080569L (no) Fremgangsmate for fremstilling av kalsiumforbindelser
FI20085707A (fi) Menetelmä pienikiteisen titaanioksidin valmistamiseksi
DE602007001151D1 (de) Verfahren zur Herstellung laufmaschenfester Textilien
ATE536885T1 (de) Produktion einer homogenen impfstoffzubereitung zur behandlung von krebs
HU0700818D0 (en) Process for the preparation of polyirocyanates of the diphenylmethone series
DE112011101390A5 (de) Verfahren zur herstellung von 4,4'-dichlordiphenylsulfon
DE502008001558D1 (de) Verfahren zur Herstellung von Aminoalkylpolysiloxanen
ES1070134Y (es) Arbol decorativo
DE112008000641A5 (de) Urformverfahren zur Herstellung von Multifunktionsbauteilen
DE112009002550A5 (de) Verfahren zur Herstellung phosphatverbrückter Nucleosidkonjugate
ES1064776Y (es) Maceta
IT1391776B1 (it) Procedimento per la preparazione di dexlansoprazolo
DE602008005504D1 (de) Verfahren zur Behandlung von Bio-Öl
TH0801005787A (th) กระบวนการสำหรับการเตรียมของเบทาอีน